FDA Guidance On Electronic Clinical Trial Data Slated For Late August
This article was originally published in The Pink Sheet Daily
Executive Summary
The guidance is expected to outline general principles that should be followed when computerized systems are used to handle electronic clinical trial data. The document will replace an April 1999 guidance on the same subject.
You may also be interested in...
FDA Good Manufacturing Practices Initiative Report Slated For October
GMP initiative report will include final guidance on process analytical technologies and aseptic processing, as well as draft guidance on the use of quality systems and computerized systems in clinical trials. The release will also contain "white paper" on prioritizing manufacturing sites for inspections.
Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.